#GLP1

Health

FDA Approves Lilly’s Foundayo, First GLP-1 Weight-Loss Pill Without Food or Water Restrictions

INDIANAPOLIS, April 2, 2026 — Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron)

Tag: #GLP1

FDA Approves Lilly’s Foundayo, First GLP-1 Weight-Loss Pill Without Food or Water Restrictions

PCFC Reinforces Transparency and Consumer Protection on Maritime Container Fees

Nine in ten finance professionals remain concerned about AI-generated insights as Middle East AI investment accelerates